Litcius/Paper detail

Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Stefan Zielen, Thomas Crawford, Luca Benatti, Mauro Magnani, Matthias Kieslich, Monique M. Ryan, Isabelle Meyts, Sheffali Gulati, Rupam Borgohain, Ravi Yadav, Pramod Kumar Pal, Anaita Hegde, Suresh Kumar, Anand Venkateswar, Vrajesh Udani, Kollencheri Puthenveettil Vinayan, Andreea Nissenkorn, Elisa Fazzi, Vincenzo Leuzzi, Asbjørg Stray‐Pedersen, Barbara Pietrucha, Samuel Ignacio Pascual Pascual, Riadh Gouider, Mary Kay Koenig, Steve W. Wu, Susan Perlman, Dirk Thye, Guenter Janhofer, Biljana Horn, William Whitehouse, Howard M. Lederman

2024The Lancet Neurology25 citationsDOIOpen Access PDF

Topics & Concepts

MedicineDiscontinuationPlaceboAtaxia-telangiectasiaDexamethasoneAtaxiaInternal medicinePediatricsPathologyPsychiatryChemistryBiochemistryDNA damageDNAAlternative medicineDNA Repair MechanismsGenetic Neurodegenerative DiseasesRadiation Therapy and Dosimetry
Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial | Litcius